Photon-counting computed tomography (PCCT) is a new technique that utilizes photon-
counting detectors to convert individual X-ray photons directly into an electrical signal, which …

Introduction The two available therapies for idiopathic pulmonary fibrosis (IPF), pirfenidone
and nintedanib, slow down but do not halt IPF progression. As such, in the last few years …

For many years has been well known that smoking could cause lung damage. Chronic
obstructive pulmonary disease and lung cancer have been the two most common smoking …

Fibrosis is the result of an overly abundant deposition of extracellular matrix (ECM) due to
the fact of repetitive tissue injuries and/or dysregulation of the repair process. Fibrogenesis …

Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF)
and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of …

Pulmonary fibrosis is a chronic, fibrotic lung disease affecting 3 million people worldwide.
The ACE2/Ang-(1–7)/MasR axis is of interest in pulmonary fibrosis due to evidence of its anti …

The prevalence of obstructive sleep apnea (OSA) has greatly increased in recent years.
Recent data suggest that severe and moderate forms of OSA affect between 6 and 17% of …

Checkpoint inhibitors are part of the family of immunotherapies and are increasingly being
used in a wide variety of cancers. Immune-related adverse events pose a major challenge in …

The diagnostic assessment of patients with Interstitial Lung Disease (ILD) can be
challenging due to the large number of possible causes. Moreover, the diagnostic approach …

Idiopathic pulmonary fibrosis (IPF) is a disease of progressive scarring caused by excessive
extracellular matrix (ECM) deposition and activation of α‐SMA‐expressing myofibroblasts …